The quest to transform injectable medications into convenient oral therapies is a major focus in pharmaceutical research. A key breakthrough in this endeavor is the development of specialized excipients that can overcome the natural barriers within the human digestive system. Among these, 8-[(2-hydroxybenzoyl)amino]octanoic acid (also known as salcaprozic acid or SNAC) has proven indispensable for enhancing the oral delivery of macromolecules like peptides and proteins.

As a leading manufacturer and supplier, we are committed to providing the pharmaceutical industry with high-quality chemical intermediates. Our 8-[(2-hydroxybenzoyl)amino]octanoic acid, with CAS number 183990-46-7, is produced to meet rigorous purity standards, making it an ideal choice for demanding pharmaceutical applications.

The Challenge of Macromolecule Oral Delivery

Macromolecules, such as peptides and proteins, are often too large and sensitive to be absorbed effectively through the intestinal wall when taken orally. They are prone to enzymatic degradation in the stomach and small intestine and face difficulties in crossing the lipid-rich cell membranes of the gut lining. This typically necessitates administration via injection, which can be painful, inconvenient, and lead to lower patient compliance.

How 8-[(2-hydroxybenzoyl)amino]octanoic Acid Solves This Problem

Our 8-[(2-hydroxybenzoyl)amino]octanoic acid acts as a sophisticated permeation enhancer, designed to facilitate the passage of these large molecules. Its effectiveness stems from several key properties:

  • Localized pH Increase: Upon oral administration, SNAC can transiently raise the local pH in the stomach. This protective microenvironment shields delicate peptide drugs from breakdown by digestive enzymes like pepsin.
  • Membrane Interaction: It interacts with the intestinal epithelium, promoting a temporary and reversible increase in membrane fluidity. This allows for enhanced passive transcellular transport of the co-administered drug.
  • Complexation: SNAC can form non-covalent complexes with drug molecules, acting as a chaperone to guide them across the intestinal barrier.

These combined actions result in significantly improved oral bioavailability, enabling oral administration of drugs that were once only feasible through injection.

Partnering with a Trusted Manufacturer and Supplier

The success of oral macromolecule therapies hinges on the quality of the permeation enhancer used. As a reputable manufacturer and supplier, we ensure that our 8-[(2-hydroxybenzoyl)amino]octanoic acid meets the highest purity specifications (>99%). This reliability is critical for pharmaceutical companies developing innovative treatments.

By choosing to buy from us, you benefit from:

  • Consistent Quality: Guaranteed purity for reliable formulation results.
  • Supply Chain Stability: A dependable source for your ongoing production needs.
  • Cost-Effectiveness: Competitive pricing for bulk purchases of this essential pharmaceutical intermediate.

The ability to administer vital peptide and protein drugs orally revolutionizes patient care. Our 8-[(2-hydroxybenzoyl)amino]octanoic acid is a key enabler of this revolution. We invite pharmaceutical researchers and developers to contact us to learn more about our product and to secure a high-quality supply for their formulation needs.